Keywords: novartis, annual, day, highlights, ahead-of-schedule, submissions, fda

Novartis' annual R&D day highlights two ahead-of-schedule submissions to US FDA

Article | 04 December 2006

• Print This

At its annual R&D day, held in London, UK, Swiss drug major Novartis reported that a number of compounds ...

Enjoying this article? To continue reading you need to login or subscribe.